Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas
- PMID: 32500575
- DOI: 10.1111/tbj.13857
Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas
Abstract
The designation of noninvasive lobular neoplasia applies to atypical epithelial proliferations composed of noncohesive cells secondary to loss or functional alteration of E-cadherin-mediated cell adhesion. The morphologic spectrum of noninvasive lobular neoplasia encompasses atypical lobular hyperplasia (ALH) and classic lobular carcinoma in situ (classic LCIS) and two LCIS variants, namely florid LCIS (F-LCIS) and pleomorphic LCIS (P-LCIS), as defined in the World Health Organization (WHO) Classification of Tumors of the Breast 5th ed. Herein, we review the morphologic, immunohistochemical, and molecular features of noninvasive lobular neoplasia, with special emphasis on F-LCIS and P-LCIS. We also review imaging features, management at core needle biopsy, upgrade rates at surgical excision, and clinical management dilemmas.
Keywords: atypical lobular hyperplasia (ALH); florid lobular carcinoma in situ (FLCIS); lobular carcinoma in situ (LCIS); pleomorphic lobular carcinoma in situ (PLCIS); upgrade.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Non-invasive Lobular Neoplasia: Review and Updates.Semin Diagn Pathol. 2025 Jul;42(4):150883. doi: 10.1016/j.semdp.2025.150883. Epub 2025 Mar 4. Semin Diagn Pathol. 2025. PMID: 40074627 Review.
-
The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.Virchows Arch. 2022 Dec;481(6):823-837. doi: 10.1007/s00428-022-03299-3. Epub 2022 May 14. Virchows Arch. 2022. PMID: 35567633 Review.
-
Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?Acad Radiol. 2022 Jul;29(7):1029-1038. doi: 10.1016/j.acra.2021.09.009. Epub 2021 Oct 23. Acad Radiol. 2022. PMID: 34702673
-
Management of Lobular Neoplasia Diagnosed by Core Biopsy.Breast J. 2023 Apr 18;2023:8185446. doi: 10.1155/2023/8185446. eCollection 2023. Breast J. 2023. PMID: 37114120 Free PMC article.
-
When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.Breast. 2016 Dec;30:125-129. doi: 10.1016/j.breast.2016.09.006. Epub 2016 Oct 4. Breast. 2016. PMID: 27718416
Cited by
-
Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.Ann Surg Oncol. 2025 Apr;32(4):2545-2553. doi: 10.1245/s10434-024-16686-8. Epub 2024 Dec 30. Ann Surg Oncol. 2025. PMID: 39738900
-
Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants.Breast Cancer Res Treat. 2024 Jun;205(3):545-554. doi: 10.1007/s10549-024-07261-6. Epub 2024 Mar 12. Breast Cancer Res Treat. 2024. PMID: 38472593
References
REFERENCES
-
- Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17(4): 491-496 3.
-
- Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42(2):737-769.
-
- Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Human Pathol. 1991;22(12):1232-1239.
-
- WHO classification of Tumours Editorial Board. Breast Tumours. Lyon, France: IARC; 2019.
-
- King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33(33):3945-3952.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical